Empiric Versus Imaging Guided Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (ImagingCRT)

September 4, 2014 updated by: University of Aarhus
The aim of this study is to investigate if imaging guided optimal left ventricular (LV) lead placement improves the response rate to cardiac resynchronization therapy (CRT). Consecutive patients meeting the standard criteria for CRT are included in a prospective, double-blinded, randomized trial to LV lead positioning either 1) guided by cardiac imaging using echocardiography, single-photon emission computed tomography, and visualization of cardiac venous anatomy (cardiac computed tomography (CT), venography) to target an epicardial vein at the site of latest mechanical activation without scar tissue or 2) using standard LV lead placement.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

182

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus N, Denmark, DK-8200
        • Department of Cardiology, Aarhus University Hospital, Skejby

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Symptomatic heart failure (New York Heart Association functional class II - IV) despite stabile optimal medical therapy.
  • ECG with QRS ≥ 120 milliseconds and left bundle branch block (LBBB) or paced QRS ≥ 180 milliseconds.
  • LV systolic dysfunction (Ejection Fraction ≤ 35%).
  • written informed consent.

Exclusion Criteria:

  • Expected lifetime < 6 months.
  • Recent myocardial infarction (< 3 months).
  • Pregnant or lactating.
  • Inadequate echocardiographic images for determination of site with latest mechanical activation
  • No written informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Imaging guided LV lead placement

LV lead placement guided by cardiac imaging using echocardiography, single-photon emission computed tomography, and CT to target a cardiac vein at the site of latest mechanical activation without scar tissue.

Visualization of cardiac venous anatomy is performed using cardiac CT if not contraindicated by depressed renal function (estimated glomerular filtration rate <30 ml/min) or allergy to contrast media. In that case, a coronary venogram is used.

No Intervention: Empiric LV lead placement
LV lead placement using standard clinical routine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with clinical response to CRT
Time Frame: 6 months after CRT implantation

Response to CRT defined as a combination of survival, free of hospitalization for heart failure, and improved functional status. The primary endpoint is attained if the patient is registered for one of the following three events:

  1. Death from any cause.
  2. Hospitalization for heart failure.
  3. No improvement in New York Heart Association (NYHA) functional class and <10% improvement in 6-minutes hall walk at end of study period.
6 months after CRT implantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cause mortality
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Hospitalization for heart failure
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes in NYHA functional class
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes in 6-Minutes Hall Walk
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes in Quality of Life
Time Frame: 6 months after CRT implantation
Using Minnesota Living with Heart Failure questionnaire.
6 months after CRT implantation
Changes in Biochemical marker of heart failure
Time Frame: 6 months after CRT implantation
Nt-ProBNP
6 months after CRT implantation
Changes in LV Ejection Fraction
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes of LV end-diastolic volume
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes of LV end-systolic volume
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes of LV dyssynchrony
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Changes of mitral regurgitation grade
Time Frame: 6 months after CRT implantation
6 months after CRT implantation
Duration of CRT implantation
Time Frame: During CRT implantation
During CRT implantation
Complications
Time Frame: 6 months after CRT implantation
6 months after CRT implantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jens C. Nielsen, Professor, PhD, DMSc, Aarhus University Hospital
  • Principal Investigator: Anders Sommer, MD, Aarhus University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

April 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

March 25, 2011

First Submitted That Met QC Criteria

March 25, 2011

First Posted (Estimate)

March 28, 2011

Study Record Updates

Last Update Posted (Estimate)

September 5, 2014

Last Update Submitted That Met QC Criteria

September 4, 2014

Last Verified

August 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • sksCRT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Imaging guided optimal LV lead placement

3
Subscribe